Fin Trust Capital Advisors, LLC Amgen Inc Transaction History

Fin Trust Capital Advisors, LLC

$577 Million
Q3 2024

A detailed history of Fin Trust Capital Advisors, LLC transactions in Amgen Inc stock. As of the latest transaction made, Fin Trust Capital Advisors, LLC holds 7,921 shares of AMGN stock, worth $2.1 Million. This represents 0.44% of its overall portfolio holdings.

Number of Shares

7,921

Previous 8,484 6.64%

Holding current value

$2.1 Million

Previous $2.65 Million 3.7%

% of portfolio

0.44%

Previous 0.5%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 11, 2024	SELL	$309.38 - $337.38 $174,180 - $189,944	-563 Reduced 6.64%	7,921 $2.55 Million
Q2 2024 Jul 24, 2024	BUY	$262.75 - $319.31 $95,378 - $115,909	363 Added 4.47%	8,484 $2.65 Million
Q1 2024 May 02, 2024	SELL	$268.87 - $324.56 $1.41 Million - $1.7 Million	-5,249 Reduced 39.26%	8,121 $2.31 Million
Q4 2023 Feb 13, 2024	BUY	$255.7 - $288.46 $1.16 Million - $1.31 Million	4,534 Added 51.31%	13,370 $3.85 Million
Q3 2023 Oct 24, 2023	SELL	$218.65 - $271.46 $52,257 - $64,878	-239 Reduced 2.63%	8,836 $2.37 Million
Q4 2022 Feb 14, 2023	BUY	$229.03 - $291.01 $412,254 - $523,818	1,800 Added 24.74%	9,075 $2.38 Million
Q3 2022 Oct 20, 2022	SELL	$224.46 - $253.15 $32,995 - $37,213	-147 Reduced 1.98%	7,275 $1.83 Million
Q1 2022 May 03, 2022	BUY	$219.27 - $242.57 $1.34 Million - $1.48 Million	6,103 Added 462.7%	7,422 $1.8 Million
Q3 2021 Nov 16, 2021	SELL	$212.27 - $248.7 $8,490 - $9,948	-40 Reduced 2.94%	1,319 $280,000
Q2 2021 Aug 16, 2021	SELL	$233.58 - $259.14 $33,635 - $37,316	-144 Reduced 9.58%	1,359 $331,000
Q1 2021 May 17, 2021	SELL	$221.91 - $258.6 $8,210 - $9,568	-37 Reduced 2.4%	1,503 $374,000
Q4 2020 Feb 16, 2021	SELL	$216.38 - $257.67 $51,931 - $61,840	-240 Reduced 13.48%	1,540 $354,000
Q3 2020 Nov 10, 2020	SELL	$234.65 - $260.95 $15,017 - $16,700	-64 Reduced 3.47%	1,780 $452,000
Q2 2020 Sep 11, 2020	BUY	$197.81 - $242.74 $364,761 - $447,612	1,844 New	1,844 $435,000
Q2 2020 Aug 14, 2020	SELL	$197.81 - $242.74 $648,025 - $795,216	-3,276 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$182.24 - $241.7 $41,186 - $54,624	-226 Reduced 6.45%	3,276 $664,000
Q4 2019 Jan 23, 2020	SELL	$189.21 - $243.2 $15,515 - $19,942	-82 Reduced 2.29%	3,502 $844,000
Q3 2019 Oct 29, 2019	BUY	$174.11 - $208.62 $34,299 - $41,098	197 Added 5.82%	3,584 $694,000
Q2 2019 Aug 01, 2019	BUY	$166.7 - $195.41 $138,527 - $162,385	831 Added 32.51%	3,387 $624,000
Q1 2019 May 09, 2019	SELL	$180.87 - $203.88 $135,471 - $152,706	-749 Reduced 22.66%	2,556 $486,000
Q4 2018 Feb 11, 2019	BUY	$178.4 - $208.25 $589,612 - $688,266	3,305 New	3,305 $643,000

Others Institutions Holding AMGN

# of Institutions

3,125

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $141B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fin Trust Capital Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fin Trust Capital Advisors, LLC with notifications on news.

Account

Fin Trust Capital Advisors, LLC Amgen Inc Transaction History